119 related articles for article (PubMed ID: 16431059)
1. Association between human beta defensin expression and cholesteatoma formation.
Meyer JE; Schwaab M; Beier UH; Görögh T; Buchelt T; Frese K; Maune S
Auris Nasus Larynx; 2006 Jun; 33(2):159-65. PubMed ID: 16431059
[TBL] [Abstract][Full Text] [Related]
2. Differential expression of human beta defensin 2 and human beta defensin 3 in human middle ear cholesteatoma.
Song JJ; Chae SW; Woo JS; Lee HM; Jung HH; Hwang SJ
Ann Otol Rhinol Laryngol; 2007 Mar; 116(3):235-40. PubMed ID: 17419529
[TBL] [Abstract][Full Text] [Related]
3. Ocular surface epithelia express mRNA for human beta defensin-2.
McNAMARA NA; Van R; Tuchin OS; Fleiszig SM
Exp Eye Res; 1999 Nov; 69(5):483-90. PubMed ID: 10548468
[TBL] [Abstract][Full Text] [Related]
4. [The expression and significance of human beta-defensin 2 in middle ear cholesteatoma epithelium].
Ren X; Cui P; Chen W; Xu M
Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2005 Apr; 19(7):313-4. PubMed ID: 16001900
[TBL] [Abstract][Full Text] [Related]
5. Expression of a cathelicidin antimicrobial peptide is augmented in cholesteatoma.
Jung HH; Chae SW; Jung SK; Kim ST; Lee HM; Hwang SJ
Laryngoscope; 2003 Mar; 113(3):432-5. PubMed ID: 12616192
[TBL] [Abstract][Full Text] [Related]
6. Expression of human beta-defensins in patients with mycosis fungoides.
Gambichler T; Skrygan M; Appelhans C; Tomi NS; Reinacher-Schick A; Altmeyer P; Kreuter A
Arch Dermatol Res; 2007 Jul; 299(4):221-4. PubMed ID: 17415576
[TBL] [Abstract][Full Text] [Related]
7. Expression of beta-defensins in human middle ear cholesteatoma.
Park K; Moon SK; Choung YH; Choi HS
Acta Otolaryngol; 2003 Jan; 123(2):236-40. PubMed ID: 12701748
[TBL] [Abstract][Full Text] [Related]
8. [Expression of transforming growth factor-beta 1 matrix metalloproteinase-1 and its inhibitor in human middle ear cholesteatoma].
Yang X; Li X; Ma M; Zhang L; Zhang Q; Wang J; Wang B
Zhonghua Er Bi Yan Hou Ke Za Zhi; 2002 Apr; 37(2):121-3. PubMed ID: 12768723
[TBL] [Abstract][Full Text] [Related]
9. Oesophageal defensin expression during Candida infection and reflux disease.
Kiehne K; Brunke G; Meyer D; Harder J; Herzig KH
Scand J Gastroenterol; 2005 May; 40(5):501-7. PubMed ID: 16036501
[TBL] [Abstract][Full Text] [Related]
10. Ultraviolet A1-induced downregulation of human beta-defensins and interleukin-6 and interleukin-8 correlates with clinical improvement in localized scleroderma.
Kreuter A; Hyun J; Skrygan M; Sommer A; Bastian A; Altmeyer P; Gambichler T
Br J Dermatol; 2006 Sep; 155(3):600-7. PubMed ID: 16911288
[TBL] [Abstract][Full Text] [Related]
11. Expression of the p53 and nm23 genes in cholesteatoma.
Bayazit YA; Bakir K; Kanlikama M; Ozer E; Mumbuc S; Disikirik I; Ucak R
Acta Otolaryngol; 2002 Oct; 122(7):726-9. PubMed ID: 12484649
[TBL] [Abstract][Full Text] [Related]
12. [The expression of matrix metalloproteinase-1 and interleukin-1-alpha messenger ribonucleic acid in human middle ear cholesteatoma].
Liu J; Lin G; Huang J; Jiang Z
Zhonghua Er Bi Yan Hou Ke Za Zhi; 2002 Feb; 37(1):30-3. PubMed ID: 12768791
[TBL] [Abstract][Full Text] [Related]
13. Expression patterns of Ki-67 and telomerase activity in middle ear cholesteatoma.
Kuczkowski J; Pawelczyk T; Bakowska A; Narozny W; Mikaszewski B
Otol Neurotol; 2007 Feb; 28(2):204-7. PubMed ID: 17255888
[TBL] [Abstract][Full Text] [Related]
14. [The expression of Ras protein in human middle ear cholesteatoma].
Xu Y; Jin K; Dong W
Zhonghua Er Bi Yan Hou Ke Za Zhi; 1999 Apr; 34(2):74-6. PubMed ID: 12764851
[TBL] [Abstract][Full Text] [Related]
15. Up-regulation of peroxidase proliferator-activated receptor gamma in cholesteatoma.
Hwang SJ; Kang HJ; Song JJ; Kang JS; Woo JS; Chae SW; Lee HM
Laryngoscope; 2006 Jan; 116(1):58-61. PubMed ID: 16481810
[TBL] [Abstract][Full Text] [Related]
16. Pattern of mRNA expression of beta-defensins in basal cell carcinoma.
Gambichler T; Skrygan M; Huyn J; Bechara FG; Sand M; Altmeyer P; Kreuter A
BMC Cancer; 2006 Jun; 6():163. PubMed ID: 16796735
[TBL] [Abstract][Full Text] [Related]
17. Human beta-defensin-1 and -2 and matrix metalloproteinase-25 and -26 expression in chronic and aggressive periodontitis and in peri-implantitis.
Kuula H; Salo T; Pirilä E; Hagström J; Luomanen M; Gutierrez-Fernandez A; Romanos GE; Sorsa T
Arch Oral Biol; 2008 Feb; 53(2):175-86. PubMed ID: 17996844
[TBL] [Abstract][Full Text] [Related]
18. Expression of beta-defensins in gingival health and in periodontal disease.
Bissell J; Joly S; Johnson GK; Organ CC; Dawson D; McCray PB; Guthmiller JM
J Oral Pathol Med; 2004 May; 33(5):278-85. PubMed ID: 15078488
[TBL] [Abstract][Full Text] [Related]
19. [Carcinoembryonic antigen in chronic otitis media with cholesteatoma].
Sanković-Babić S; Sofronić-Milosavljević Lj
Srp Arh Celok Lek; 2000; 128(3-4):80-3. PubMed ID: 10932614
[TBL] [Abstract][Full Text] [Related]
20. [Expression of transforming growth factor-beta1 and c-fos and p27 in human middle ear cholesteatoma].
Jiang CW; Zhan HM; Wang WH; Zhang L; Jin SZ; Yang YB; Zhang ZJ
Zhonghua Er Bi Yan Hou Ke Za Zhi; 2004 Apr; 39(4):211-5. PubMed ID: 15283280
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
